Dr.ย Joon Ohย Park
MD, PhD
Professor, Division of Hematology-Oncology
corporate_fareSamsung Medical Center, Seoul
Joon Oh Park
MD, PhD
Prof. Joon Oh Park, MD, PhD, is a Professor in the Division of Hematology-Oncology at Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, South Korea. He specialises in gastrointestinal and pancreatobiliary cancers, with officially listed clinical expertise in pancreatic cancer and bile duct cancer, including cholangiocarcinoma.
Prof. Park completed his medical training at Yonsei University College of Medicine and earned his PhD in Medicine from Yonsei University Graduate School of Medical Science. He furthered his oncology expertise with a postdoctoral fellowship at Dana-Farber Cancer Institute and Harvard Medical School in Boston, USA from 2006 to 2008. Since joining Samsung Medical Center, he has served as Associate Professor and then Professor since 2013, building over 20 years of clinical and research experience in complex gastrointestinal malignancies. He has served as Director of the Precision Medicine Research Center at Samsung Research Institute for Future Medicine since 2019 and previously led the Center for Rare Cancers at Samsung Comprehensive Cancer Center from 2015 to 2021. His academic profile at Sungkyunkwan University is associated with more than 380 research outputs.
Samsung Medical Center is one of South Korea's leading internationally recognised cancer centres. CancerFax can coordinate report review and consultation support for overseas patients seeking an opinion from Prof. Park.
Why Consider Prof. Joon Oh Park?
Prof. Park brings over two decades of focused experience in gastrointestinal and pancreatobiliary oncology at one of Asia's most internationally recognised cancer centres, combined with leadership in precision medicine and clinical research.
Areas of Specialisation
Gastrointestinal, pancreatobiliary, and rare cancer care at Samsung Medical Center
Prof. Park's clinical practice focuses on systemic oncology for complex gastrointestinal and pancreatobiliary cancers, supported by translational research and precision medicine programmes at Samsung Medical Center.
Pancreatobiliary Cancer
Officially listed clinical expertise at Samsung Medical Center in pancreatic cancer and bile duct cancer, including cholangiocarcinoma.
- arrow_rightSystemic treatment planning for resectable and advanced pancreatic cancer
- arrow_rightChemotherapy regimens including gemcitabine-based and FOLFIRINOX protocols
- arrow_rightIntegration of precision diagnostics for treatment selection
- arrow_rightMedical oncology for intrahepatic and extrahepatic cholangiocarcinoma
- arrow_rightTargeted therapy where molecular profiling supports it
- arrow_rightMultidisciplinary management within Samsung's Pancreatobiliary Cancer Center
Gastrointestinal Oncology
Broad GI cancer expertise supported by clinical research including gastric cancer trial activity and colorectal cancer centre affiliation.
- arrow_rightSystemic therapy for advanced colorectal cancer
- arrow_rightAffiliation with Samsung Medical Center's Colorectal Cancer Center
- arrow_rightChemotherapy and targeted treatment planning for eligible patients
- arrow_rightClinical research and trial participation in advanced gastric cancer
- arrow_rightCombination systemic therapy approaches including CAPEOX-based regimens
- arrow_rightMolecularly guided treatment evaluation for selected patients
Rare Cancers & Precision Oncology
Former Director of the Center for Rare Cancers at Samsung Comprehensive Cancer Center, with expertise in complex and uncommon malignancies.
- arrow_rightMultidisciplinary rare cancer care within Samsung Comprehensive Cancer Center
- arrow_rightAccess to precision medicine pathways for patients with uncommon tumour types
- arrow_rightIntegration of research findings into clinical decision-making
Procedures Performed
Systemic oncology services and clinical approaches at Samsung Medical Center
Prof. Park's practice centres on systemic cancer treatment planning for gastrointestinal and pancreatobiliary malignancies, supported by molecular diagnostics, clinical trial access, and multidisciplinary care.
Systemic Cancer Treatment
Medical OncologyChemotherapy, immunotherapy, and combination regimen planning for GI and pancreatobiliary cancers.
Targeted Therapy
Targeted TherapyMolecularly guided targeted agents for GI cancers where supported by pathology and biomarker results.
Complex Disease Management
Complex DiseaseMultidisciplinary care for advanced, rare, or refractory GI cancers through Samsung's specialised cancer centre network.
Second Opinion Consultations
Second OpinionIndependent expert review of pathology, imaging, and treatment history for GI and pancreatobiliary cancer cases.
Research & Publications
Extensive research output in gastrointestinal oncology and clinical trial participation
Prof. Park has a substantial academic research record. His Sungkyunkwan University academic profile lists more than 380 research outputs, with a research fingerprint spanning chemotherapy for abdominal cancers, biliary tract cancer, gemcitabine, cisplatin, chemoradiation therapy, and overall survival outcomes.
Prof. Park's active role in precision medicine research at Samsung Medical Center means eligible patients may have access to advanced diagnostics and molecularly guided treatment pathways. CancerFax can help coordinate case review.
Education & Training
Prof. Park completed his undergraduate and postgraduate medical training at Yonsei University in Seoul, followed by clinical oncology fellowships in Korea and a postdoctoral research fellowship at Dana-Farber Cancer Institute and Harvard Medical School in Boston.
Clinical Experience
Prof. Park has built his entire clinical and academic career in the Division of Hematology-Oncology at Samsung Medical Center, rising from Clinical Fellow to Professor over more than two decades, while leading major institutional research and clinical programmes.
Languages & International
Prof. Park conducts consultations in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients who require assistance in languages other than English or Korean.
CancerFax can coordinate professional medical interpreter support for patients consulting in other languages.
How CancerFax Helps You Access Dr. Joon Oh Park
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Joon Oh Park's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Joon Oh Park's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Joon Oh Park before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Joon Oh Park's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Joon Oh Park's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Joon Oh Park's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Joon Oh Park
Prof. Park's official clinical expertise at Samsung Medical Center is listed as pancreatic cancer and bile duct cancer, including cholangiocarcinoma. He is also affiliated with the Colorectal Cancer Center and Pancreatobiliary Cancer Center, and has a clinical research background in gastric cancer and rare cancers.
Prof. Park is a Professor in the Division of Hematology-Oncology at Samsung Medical Center in Seoul, South Korea, affiliated with Sungkyunkwan University School of Medicine. Samsung Medical Center is one of South Korea's most internationally recognised cancer care institutions.
Samsung Medical Center has an established international healthcare services pathway for overseas patients. CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Park, subject to hospital availability and case acceptance.
Submit your medical reports through CancerFax using the Send Your Reports button. The CancerFax team will review your documents, prepare a structured case summary, and coordinate the next steps with Samsung Medical Center, subject to availability and case suitability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. The CancerFax team will structure the submission and coordinate the review process with Samsung Medical Center. The final consultation format and availability depend on the doctor's institution.
Prof. Park's practice focuses on systemic oncology for gastrointestinal and pancreatobiliary cancers, including chemotherapy (gemcitabine, FOLFIRINOX, CAPEOX), targeted therapy where supported by molecular profiling, and immunotherapy for eligible patients. He also leads the Precision Medicine Research Center at Samsung, enabling molecularly guided treatment pathways for suitable cases.
Connect with Joon Oh Park Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.